On the afternoon of June 10, 2022, Lu Cailiu, Vice Mayor of Lishui City, Hu Xianru, Director of the Municipal Bureau of Economy and Information Technology, Wu Yuyu, Director of the Municipal Health Commission, Xie Xiaoyan, Deputy Director of the Municipal Bureau of Culture, Radio, Television, Tourism and Sports, and Chen Lei, Deputy Director of the Lishui Development Zone Management Committee, visited Zhejiang Benefit Pharmaceutical for research and guidance. Wu Lihua, Chairman of the company, and relevant senior leaders accompanied the research.

Zhang Liyun, Administrative Director, introduced various production links and R&D situations through a remote real-time video system, and gave a brief report on the development of the company's four business sectors, corporate culture, and Benefit's future layout plan for the extension of the traditional Chinese medicine industry.

Subsequently, Chairman Wu Lihua exchanged views with the research team leaders on the production technology, product convenience, quality assurance, effectiveness of traditional Chinese medicine formula granules, and the efficacy of single-flavor traditional Chinese medicine formula granules.

At the forum, Chairman Wu Lihua reported on traditional Chinese medicine formula granule products, industry status, modern traditional Chinese medicine industry layout, and enterprise business situation, focusing on exchanging views on the product characteristics of traditional Chinese medicine formula granules and the three major directions of the company's future development.

The research team leaders spoke highly of Benefit's traditional Chinese medicine formula granules, stating that they are convenient for patients to carry around and can be taken immediately after brewing, which plays a positive role in promoting the modernization, standardization, and internationalization of traditional Chinese medicine.

Finally, Mayor Lu pointed out that coordinating epidemic prevention and control with economic development is the top priority at present, and pharmaceutical production and R&D enterprises are characterized by their dual connection with epidemic prevention and control and economic development. Relevant government departments and enterprises should make two-way efforts to implement the spirit and requirements related to stable progress and quality improvement, and promote the implementation of policies. At the same time, relevant government departments will continue to保驾护航 the healthy development of pharmaceutical enterprises! The development of modern traditional Chinese medicine has a long way to go with both opportunities and challenges. It is hoped that Benefit can continue to explore new approaches and, by leveraging the advantages of traditional Chinese medicine formula granules such as precise ingredient content and definite efficacy, contribute to the field of inheritance and development of traditional Chinese medicine!